Cambium Bio Limited
CMB
Rangering i aksjer
#32500
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Aksjekurs
$0.31737816
Markedsverdi
$9.34M
Endring (1 dag)
0.00%
Endring (1 år)
5,917.33%
Land
AU
Handel Cambium Bio Limited (CMB)
Kategori
Healthcare
Historikk for aksjesplitt for Cambium Bio Limited (CMB)
Aksjen Cambium Bio Limited (symbol: CMB) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én CMB-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 CMB-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én CMB-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 CMB-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
